Basal-cell adenocarcinoma of the salivary gland is a low-grade malignant neoplasm

1997 ◽  
Vol 4 (3) ◽  
pp. 183
Author(s):  
&NA;
2017 ◽  
Vol 23 (4) ◽  
pp. 184-188
Author(s):  
Ananya Madiyal ◽  
Babu G. Subhas ◽  
Vidya Ajila ◽  
Shruthi Hegde

Abstract Basal cell adenocarcinoma is an unusual basaloid tumour that usually affects the parotid and very rarely involves the submandibular or minor salivary glands. It constitutes 1.6% of all salivary gland tumours and occurs as an asymptomatic freely mobile mass with occasional lymph node metastasis. Differentiation from benign salivary gland tumours like basal cell adenoma is accomplished by determining the depth of tumour invasion and patterns of growth or infiltration. Although it is categorised as a low-grade malignancy, it has a high propensity for recurrence. Surgical excision with a wide margin is the preferred course of treatment with radiotherapy being reserved only for tumours of the minor salivary glands with a diffuse pattern of infiltration. We present here a case of basal cell adenocarcinoma with a rare presentation in the minor salivary glands of the tongue which arose from a previously treated basal cell adenoma in the same site.


1996 ◽  
Vol 115 (1) ◽  
pp. 150-151 ◽  
Author(s):  
Ashutosh Kacker ◽  
Volkan Adsay ◽  
Arnold Komisar

The term basal cell adenoma was used by Kleinsasser and Klien 1 in 1967 to describe benign salivary gland tumors comprised of a single type of epithelium. Basal cell adenocarcinoma is a relatively new entity, and there are only a few cases reported in the literature. It has a morphology like that of a basal cell adenoma but has growth characteristics of a malignant neoplasm.


1993 ◽  
Vol 107 (9) ◽  
pp. 862-864 ◽  
Author(s):  
Timo Atula ◽  
Pekka-Juhani Klemi ◽  
Karl Donath ◽  
Risto-Pekka Happonen ◽  
Heikki Joensuu ◽  
...  

AbstractBasal cell adenocarcinoma is a rare salivary gland tumour. A DNA diploid parotid gland basal cell adenocarcinoma, with a low mitotic rate, in a 78-year-old female patient is described. Total removal of the affected salivary gland without sacrificing the facial nerve gave a good therapeutic result.


2015 ◽  
Vol 141 (3) ◽  
pp. 276 ◽  
Author(s):  
David W. Cuthbertson ◽  
Nikhila Raol ◽  
John Hicks ◽  
Linda Green ◽  
Robert Parke

2018 ◽  
Vol 159 ◽  
pp. 21-25 ◽  
Author(s):  
J. Díaz-Delgado ◽  
A.A.C. Coimbra ◽  
C. dos Santos-Cirqueira ◽  
T.C. Sanches ◽  
J.M. Guerra ◽  
...  

2010 ◽  
Vol 3 ◽  
pp. CPath.S3303 ◽  
Author(s):  
Mari Markkanen-Leppänen ◽  
Antti A. Mäkitie ◽  
Fabricio Passador-Santos ◽  
Ilmo Leivo ◽  
Jaana Hagström

We report a rare case of bilateral basal cell adenocarcinoma (BcAC) of the parotid gland in a male patient 30 years after kidney transplantation and continuous administration of immunosuppressive therapy. BcAC is a salivary gland malignancy first recognized as a distinct neoplastic entity in WHO classification of salivary gland tumours in 1991. Over 90% of BcACs are detected in the parotid gland. The most important differential diagnosis is basal cell adenoma. Infiltrative growth is the distinguishing feature of BcAC. Administration of immunosuppressive medication to this patient for three decades may have contributed to development of this rare neoplasia. To our knowledge, similar cases of BcAC have not been reported previously.


2000 ◽  
Vol 58 (7) ◽  
pp. 811-814 ◽  
Author(s):  
Takeshi Wada ◽  
Nobuo Morita ◽  
Tadayuki Sakamoto ◽  
Hirokazu Nakamine

Sign in / Sign up

Export Citation Format

Share Document